Evaluation of a new mobile system for protecting immune-suppressed patients against airborne contamination

Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient prot...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of infection control Vol. 35; no. 7; pp. 460 - 466
Main Authors Poirot, Jean-Louis, Gangneux, Jean-Pierre, Fischer, Alain, Malbernard, Mireille, Challier, Svetlana, Laudinet, Nicolas, Bergeron, Vance
Format Journal Article
LanguageEnglish
Published United States Mosby, Inc 01.09.2007
Elsevier
Subjects
Online AccessGet full text
ISSN0196-6553
1527-3296
DOI10.1016/j.ajic.2007.02.006

Cover

Loading…
Abstract Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment. Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals. Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m 3) regardless of the levels in the room or corridor ( P < .01). These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting.
AbstractList Background Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment. Methods Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals. Results Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m3 ) regardless of the levels in the room or corridor ( P < .01). Conclusions These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting.
Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment. Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals. Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m 3) regardless of the levels in the room or corridor ( P < .01). These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting.
BACKGROUND: Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment. METHODS: Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals. RESULTS: Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m(3)) regardless of the levels in the room or corridor (P < .01). CONCLUSIONS: These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting.
Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment. Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals. Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m(3)) regardless of the levels in the room or corridor (P < .01). These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting.
Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment.BACKGROUNDInvasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats requires costly and high-maintenance facilities. We herein evaluate a new self-contained mobile unit as an alternative for creating a patient protective environment.Airborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals.METHODSAirborne contamination levels were monitored for different simulated scenarios and under actual clinical conditions. Functional tests were used to challenge the unit under adverse conditions, and a preliminary clinical study with patients and staff present was performed at 2 different French hospitals.Functional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m(3)) regardless of the levels in the room or corridor (P < .01).RESULTSFunctional tests demonstrated that the unit can rapidly decontaminate air in the protected zone created by the unit and in the surrounding room. In addition, the protected zone is not sensitive to large disturbances that occur in the room. The clinical study included 4 patients with 150 accumulated days of testing. The protected zone created by the unit systematically provided an environment with undetectable airborne fungal levels (ie, <1 CFU/m(3)) regardless of the levels in the room or corridor (P < .01).These tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting.CONCLUSIONSThese tests show that the unit can be used to create a mobile protective environment for immune-suppressed patients in a standard hospital setting.
Author Fischer, Alain
Challier, Svetlana
Malbernard, Mireille
Bergeron, Vance
Gangneux, Jean-Pierre
Poirot, Jean-Louis
Laudinet, Nicolas
Author_xml – sequence: 1
  givenname: Jean-Louis
  surname: Poirot
  fullname: Poirot, Jean-Louis
  organization: Hôpital Saint-Antoine, Laboratoire de Parasitologie-Mycologie, Paris, France
– sequence: 2
  givenname: Jean-Pierre
  surname: Gangneux
  fullname: Gangneux, Jean-Pierre
  organization: Centre Hospitalier Universitaire de Rennes, Laboratoire de Parasitologie-Mycologie, Rennes, France
– sequence: 3
  givenname: Alain
  surname: Fischer
  fullname: Fischer, Alain
  organization: Hôpital Necker, Service d'Immuno-Hématologie Pédiatrique, Paris, France
– sequence: 4
  givenname: Mireille
  surname: Malbernard
  fullname: Malbernard, Mireille
  organization: Hôpital Necker, Service d'Immuno-Hématologie Pédiatrique, Paris, France
– sequence: 5
  givenname: Svetlana
  surname: Challier
  fullname: Challier, Svetlana
  organization: Laboratoire de Microbiologie, Paris, France
– sequence: 6
  givenname: Nicolas
  surname: Laudinet
  fullname: Laudinet, Nicolas
  organization: irInSpace SAS, Montigny-le-Bretonneux, France
– sequence: 7
  givenname: Vance
  surname: Bergeron
  fullname: Bergeron, Vance
  email: vance.bergeron@ens-lyon.fr
  organization: Ecole Normale Supérieure de Lyon, Laboratoire de Physique CNRS UMR 5672, Lyon, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17765558$$D View this record in MEDLINE/PubMed
https://hal.science/hal-00690447$$DView record in HAL
BookMark eNqFkl-L1DAUxYOsuLOjX8AHyZPgQ8ebtE1bEWFZ9o8w4IP6HNL0dk1tkzFJR-bbm-6sCguuT4HL-Z0k59wzcmKdRUJeMtgwYOLtsFGD0RsOUG2AbwDEE7JiJa-ynDfihKyANSITZZmfkrMQBgBoclE-I6esqtK4rFdkuNyrcVbROEtdTxW1-JNOrjUj0nAIESfaO0933kXU0dhbaqZptpiFebfzGAJ2dJdwtDFQdauMDZEq41vnLVLtbFSTsXf-z8nTXo0BX9yfa_L16vLLxU22_XT98eJ8m-miKWKmsevyHGohEHWnlaoE53VZFApyhhyU7usWWKn7qhVcVFqXGjhri04p7FqWr8mbo-83NcqdN5PyB-mUkTfnW7nMUlANFEW1X7Svj9r0wR8zhignEzSOo7Lo5iBFzXlZpwTX5NW9cG4n7P74_k4yCfhRoL0LwWP_VwJyqUsOcqlLLnVJ4MsrElQ_gLSJd2FFr8z4OPr-iGKKcm_Qy6BTCyk941NTsnPmcfzDA1yPxhqtxu94wDC42dtUkmQyJEB-XlZp2SSoAArRLIG8-7fB_27_BXZ92ms
CitedBy_id crossref_primary_10_1016_j_jhin_2022_06_013
crossref_primary_10_1016_S1773_035X_08_73334_3
crossref_primary_10_1016_j_ajic_2009_09_014
crossref_primary_10_1016_j_buildenv_2020_106643
crossref_primary_10_1016_j_ajic_2008_12_006
crossref_primary_10_1017_ice_2016_81
crossref_primary_10_1016_j_jhin_2022_02_002
crossref_primary_10_1016_j_jhin_2025_02_015
crossref_primary_10_3109_13693786_2011_575890
crossref_primary_10_1016_j_jhin_2010_08_012
crossref_primary_10_1007_s12553_020_00480_z
crossref_primary_10_1016_j_jhin_2008_03_018
crossref_primary_10_1016_j_jopr_2013_01_013
crossref_primary_10_1017_ice_2017_18
Cites_doi 10.1086/647679
10.1086/647317
10.1086/377537
10.1086/501661
10.1086/341318
10.1097/00006454-199808000-00011
10.1078/1438-4639-00054
10.1053/jhin.2001.0998
10.1053/jhin.2002.1308
10.1017/S0195941700067114
10.1016/0002-9343(87)90902-8
10.1111/j.1399-3062.2004.00047.x
10.1080/15428119791012252
10.1016/j.jhin.2005.03.004
10.1016/S0195-6701(98)90326-7
10.1007/s10295-005-0226-1
ContentType Journal Article
Copyright 2007 Association for Professionals in Infection Control and Epidemiology, Inc.
Association for Professionals in Infection Control and Epidemiology, Inc.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2007 Association for Professionals in Infection Control and Epidemiology, Inc.
– notice: Association for Professionals in Infection Control and Epidemiology, Inc.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
DOI 10.1016/j.ajic.2007.02.006
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList



MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1527-3296
EndPage 466
ExternalDocumentID oai_HAL_hal_00690447v1
17765558
10_1016_j_ajic_2007_02_006
S0196655307004695
1_s2_0_S0196655307004695
Genre Evaluation Studies
Journal Article
GeographicLocations France
GeographicLocations_xml – name: France
GroupedDBID ---
--K
--M
..I
.1-
.FO
.GJ
.~1
0-6
0R~
1B1
1P~
1RT
1Z5
1~.
1~5
23M
2KS
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
71M
8P~
9JM
AAAJQ
AABNK
AABSN
AAEDT
AAEDW
AAIKC
AAIKJ
AAKOC
AALRI
AAMNW
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACJTP
ACRLP
ACRPL
ACVFH
ACXZT
ADBBV
ADCNI
ADEZE
ADIMB
ADMUD
ADNMO
ADVLN
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXBA
AFXIZ
AGBRE
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BEEDS
BKOJK
BLXMC
BNPGV
C45
CAG
CJTIS
COF
COPKO
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FAFAN
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEJ
HMK
HMO
HVGLF
HZ~
H~W
IH2
IHE
J1W
J5H
K-O
KOM
L7B
LUGTX
M27
M41
MO0
N4W
N9A
O-L
O9-
OAUVE
OD-
OEN
OMK
ONC
ONOOK
OO.
OUGNH
OVD
OZT
P-8
P-9
PC.
PQQKQ
Q38
R2-
ROL
RPZ
SAE
SDF
SDG
SDP
SEL
SES
SEW
SNC
SND
SNG
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UHS
UV1
WH7
WOQ
WOW
WUQ
XCE
YFH
YOC
Z5R
ZGI
ZXP
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AISVY
AJBFU
EFLBG
LCYCR
NAHTW
ZA5
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
ID FETCH-LOGICAL-c494t-cedd330866eecdcaa76228544a031e20acf8b015cf7b6267cc5c021b4daaedb13
IEDL.DBID AIKHN
ISSN 0196-6553
IngestDate Sat Jul 26 06:31:18 EDT 2025
Mon Jul 21 10:17:27 EDT 2025
Mon Jul 21 06:03:34 EDT 2025
Thu Apr 24 23:10:54 EDT 2025
Tue Jul 01 01:59:08 EDT 2025
Fri Feb 23 02:29:53 EST 2024
Sun Feb 23 10:19:18 EST 2025
Tue Aug 26 19:31:39 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c494t-cedd330866eecdcaa76228544a031e20acf8b015cf7b6267cc5c021b4daaedb13
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0002-4974-5607
PMID 17765558
PQID 68225855
PQPubID 23479
PageCount 7
ParticipantIDs hal_primary_oai_HAL_hal_00690447v1
proquest_miscellaneous_68225855
pubmed_primary_17765558
crossref_primary_10_1016_j_ajic_2007_02_006
crossref_citationtrail_10_1016_j_ajic_2007_02_006
elsevier_sciencedirect_doi_10_1016_j_ajic_2007_02_006
elsevier_clinicalkeyesjournals_1_s2_0_S0196655307004695
elsevier_clinicalkey_doi_10_1016_j_ajic_2007_02_006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2007-09-01
PublicationDateYYYYMMDD 2007-09-01
PublicationDate_xml – month: 09
  year: 2007
  text: 2007-09-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle American journal of infection control
PublicationTitleAlternate Am J Infect Control
PublicationYear 2007
Publisher Mosby, Inc
Elsevier
Publisher_xml – name: Mosby, Inc
– name: Elsevier
References Cornet, Levy, Fleury, Lortholary, Barguins, Coureul (bib8) 1999; 20
Price, Simmons, Crow, Ahearn (bib15) 2005; 32
Sherertz, Belani, Kramer, Elfenbein, Weiner, Sullivan (bib7) 1987; 83
Centers for Disease Control and Prevention (bib1) 1997; 46
Alberti, Bouakline, Ribaud, Lacroix, Rousselot, Leblanc (bib2) 2001; 48
Health Canada (bib3) 2001; 27
Uduman, Farrukh, Nath, Zuhair, Ifrahf, Khawla (bib13) 2002; 52
Carter, Barr (bib4) 1997; 18
Loo, Bertrand, Dixon, Vitye, DeSalis, McLean (bib5) 1996; 17
Simmons, Price, Noble, Crow, Ahearn (bib16) 1997; 58
Moritz, Peters, Nipko, Ruden (bib17) 2001; 203
Griffiths, Bennett, Speight, Parks (bib14) 2005; 61
Kumari, Haji, Keer, Hawkey, Duncanson, Flower (bib11) 1998; 39
Gangneux, Bretagne, Cordonnier, Datry, Derouin, Grillot (bib18) 2002; 35
Munoz, Guinea, Pelaez, Duran, Blanco, Bouza (bib10) 2004; 6
Weems, Davis, Tablan, Kaufman, Martone (bib6) 1987; 8
McDonald, Walker, Carson, Arduino, Aguero, Gomez (bib12) 1998; 17
Lutz, Jin, Rinaldi, Wickes, Huycke (bib9) 2003; 37
Centers for Disease Control and Prevention (10.1016/j.ajic.2007.02.006_bib1) 1997; 46
Health Canada (10.1016/j.ajic.2007.02.006_bib3) 2001; 27
Cornet (10.1016/j.ajic.2007.02.006_bib8) 1999; 20
Carter (10.1016/j.ajic.2007.02.006_bib4) 1997; 18
Simmons (10.1016/j.ajic.2007.02.006_bib16) 1997; 58
Griffiths (10.1016/j.ajic.2007.02.006_bib14) 2005; 61
Kumari (10.1016/j.ajic.2007.02.006_bib11) 1998; 39
Gangneux (10.1016/j.ajic.2007.02.006_bib18) 2002; 35
Munoz (10.1016/j.ajic.2007.02.006_bib10) 2004; 6
Moritz (10.1016/j.ajic.2007.02.006_bib17) 2001; 203
Weems (10.1016/j.ajic.2007.02.006_bib6) 1987; 8
Price (10.1016/j.ajic.2007.02.006_bib15) 2005; 32
Lutz (10.1016/j.ajic.2007.02.006_bib9) 2003; 37
McDonald (10.1016/j.ajic.2007.02.006_bib12) 1998; 17
Uduman (10.1016/j.ajic.2007.02.006_bib13) 2002; 52
Loo (10.1016/j.ajic.2007.02.006_bib5) 1996; 17
Sherertz (10.1016/j.ajic.2007.02.006_bib7) 1987; 83
Alberti (10.1016/j.ajic.2007.02.006_bib2) 2001; 48
References_xml – volume: 32
  start-page: 319
  year: 2005
  end-page: 321
  ident: bib15
  article-title: Mold colonization during use of preservative-treated and untreated air filters, including HEPA filters from hospitals and commercial locations over an 8-year period (1996-2003)
  publication-title: J Ind Micobiol Biotechnol
– volume: 17
  start-page: 716
  year: 1998
  end-page: 722
  ident: bib12
  article-title: Outbreak of
  publication-title: Pediatr Infect Dis J
– volume: 52
  start-page: 175
  year: 2002
  end-page: 180
  ident: bib13
  article-title: An Outbreak of
  publication-title: J Hosp Infect
– volume: 35
  start-page: 343
  year: 2002
  end-page: 346
  ident: bib18
  article-title: Prevention of nosocomial fungal infection: the French approach
  publication-title: Clin Infect Dis
– volume: 46
  start-page: 1
  year: 1997
  end-page: 79
  ident: bib1
  article-title: Guidelines for prevention of nosocomial pneumonia
  publication-title: MMWR
– volume: 48
  start-page: 198
  year: 2001
  end-page: 206
  ident: bib2
  article-title: Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients
  publication-title: J Hosp Infect
– volume: 20
  start-page: 508
  year: 1999
  end-page: 513
  ident: bib8
  article-title: Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against
  publication-title: Infect Control Hosp Epidemiol
– volume: 83
  start-page: 709
  year: 1987
  end-page: 718
  ident: bib7
  article-title: Impact of air filtration on nosocomial
  publication-title: Am J Med
– volume: 203
  start-page: 401
  year: 2001
  end-page: 409
  ident: bib17
  article-title: Capability of air filters to retain airborne bacteria and molds in heating, ventilating and air-conditioning (HVAC) systems
  publication-title: Int Hyg Environ Health
– volume: 17
  start-page: 360
  year: 1996
  end-page: 364
  ident: bib5
  article-title: Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit
  publication-title: Infect Control Hosp Epidemiol
– volume: 37
  start-page: 786
  year: 2003
  end-page: 793
  ident: bib9
  article-title: Outbreak of invasive
  publication-title: Clin Infect Dis
– volume: 61
  start-page: 242
  year: 2005
  end-page: 247
  ident: bib14
  article-title: Determining the performance of a commercial air purification system for reducing airborne contamination using model micro-organisms: a new test methodology
  publication-title: J Hosp Infect
– volume: 58
  start-page: 900
  year: 1997
  end-page: 904
  ident: bib16
  article-title: Fungal colonization of air filters from hospitals
  publication-title: AIHA J
– volume: 18
  start-page: 587
  year: 1997
  end-page: 596
  ident: bib4
  article-title: Infection control issues in construction and renovation
  publication-title: Infect Control Hosp Epidemiol
– volume: 8
  start-page: 71
  year: 1987
  end-page: 75
  ident: bib6
  article-title: Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy
  publication-title: Infect Control
– volume: 6
  start-page: 50
  year: 2004
  end-page: 54
  ident: bib10
  article-title: Nosocomial invasive aspergillosis in a heart transplant patient acquired during a break in the HEPA air filtration system
  publication-title: Transpl Infect Dis
– volume: 39
  start-page: 127
  year: 1998
  end-page: 133
  ident: bib11
  article-title: Ventilation grilles as a potential source of methicillin-resistant
  publication-title: J Hosp Infect
– volume: 27
  start-page: 1
  year: 2001
  end-page: 46
  ident: bib3
  article-title: Construction-related nosocomial infections in patients in healthcare facilities: decreasing the risk of
  publication-title: Can Commun Dis Rep
– volume: 18
  start-page: 587
  year: 1997
  ident: 10.1016/j.ajic.2007.02.006_bib4
  article-title: Infection control issues in construction and renovation
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1086/647679
– volume: 17
  start-page: 360
  year: 1996
  ident: 10.1016/j.ajic.2007.02.006_bib5
  article-title: Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1086/647317
– volume: 37
  start-page: 786
  year: 2003
  ident: 10.1016/j.ajic.2007.02.006_bib9
  article-title: Outbreak of invasive Aspergillus infection in surgical patients, associated with a contaminated air-handling system
  publication-title: Clin Infect Dis
  doi: 10.1086/377537
– volume: 20
  start-page: 508
  year: 1999
  ident: 10.1016/j.ajic.2007.02.006_bib8
  article-title: Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1086/501661
– volume: 35
  start-page: 343
  year: 2002
  ident: 10.1016/j.ajic.2007.02.006_bib18
  article-title: Prevention of nosocomial fungal infection: the French approach
  publication-title: Clin Infect Dis
  doi: 10.1086/341318
– volume: 27
  start-page: 1
  issue: Suppl 2
  year: 2001
  ident: 10.1016/j.ajic.2007.02.006_bib3
  article-title: Construction-related nosocomial infections in patients in healthcare facilities: decreasing the risk of Aspergillus, Legionella and other infections
  publication-title: Can Commun Dis Rep
– volume: 17
  start-page: 716
  year: 1998
  ident: 10.1016/j.ajic.2007.02.006_bib12
  article-title: Outbreak of Acinetobacter spp. Bloodstream infections in a nursery associated with contaminated aerosols and air conditioners
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/00006454-199808000-00011
– volume: 203
  start-page: 401
  year: 2001
  ident: 10.1016/j.ajic.2007.02.006_bib17
  article-title: Capability of air filters to retain airborne bacteria and molds in heating, ventilating and air-conditioning (HVAC) systems
  publication-title: Int Hyg Environ Health
  doi: 10.1078/1438-4639-00054
– volume: 48
  start-page: 198
  year: 2001
  ident: 10.1016/j.ajic.2007.02.006_bib2
  article-title: Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients
  publication-title: J Hosp Infect
  doi: 10.1053/jhin.2001.0998
– volume: 52
  start-page: 175
  year: 2002
  ident: 10.1016/j.ajic.2007.02.006_bib13
  article-title: An Outbreak of Serratia marcescens infection in a special-care baby unit of a community hospital in United Arab Emirates: the importance of the air conditioner duct as a nosocomial reservoir
  publication-title: J Hosp Infect
  doi: 10.1053/jhin.2002.1308
– volume: 8
  start-page: 71
  year: 1987
  ident: 10.1016/j.ajic.2007.02.006_bib6
  article-title: Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy
  publication-title: Infect Control
  doi: 10.1017/S0195941700067114
– volume: 83
  start-page: 709
  year: 1987
  ident: 10.1016/j.ajic.2007.02.006_bib7
  article-title: Impact of air filtration on nosocomial Aspergillus infections: unique risk of bone marrow transplant recipients
  publication-title: Am J Med
  doi: 10.1016/0002-9343(87)90902-8
– volume: 6
  start-page: 50
  year: 2004
  ident: 10.1016/j.ajic.2007.02.006_bib10
  article-title: Nosocomial invasive aspergillosis in a heart transplant patient acquired during a break in the HEPA air filtration system
  publication-title: Transpl Infect Dis
  doi: 10.1111/j.1399-3062.2004.00047.x
– volume: 58
  start-page: 900
  year: 1997
  ident: 10.1016/j.ajic.2007.02.006_bib16
  article-title: Fungal colonization of air filters from hospitals
  publication-title: AIHA J
  doi: 10.1080/15428119791012252
– volume: 61
  start-page: 242
  year: 2005
  ident: 10.1016/j.ajic.2007.02.006_bib14
  article-title: Determining the performance of a commercial air purification system for reducing airborne contamination using model micro-organisms: a new test methodology
  publication-title: J Hosp Infect
  doi: 10.1016/j.jhin.2005.03.004
– volume: 46
  start-page: 1
  year: 1997
  ident: 10.1016/j.ajic.2007.02.006_bib1
  article-title: Guidelines for prevention of nosocomial pneumonia
  publication-title: MMWR
– volume: 39
  start-page: 127
  year: 1998
  ident: 10.1016/j.ajic.2007.02.006_bib11
  article-title: Ventilation grilles as a potential source of methicillin-resistant Staphylococcus aureus causing an outbreak in an orthopaedic ward at a district general hospital
  publication-title: J Hosp Infect
  doi: 10.1016/S0195-6701(98)90326-7
– volume: 32
  start-page: 319
  year: 2005
  ident: 10.1016/j.ajic.2007.02.006_bib15
  article-title: Mold colonization during use of preservative-treated and untreated air filters, including HEPA filters from hospitals and commercial locations over an 8-year period (1996-2003)
  publication-title: J Ind Micobiol Biotechnol
  doi: 10.1007/s10295-005-0226-1
SSID ssj0009365
Score 1.9003056
Snippet Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne threats...
Background Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne...
BACKGROUND: Invasive aspergillosis is one of the most lethal airborne dangers for immune-suppressed subjects. Providing patient protection from such airborne...
SourceID hal
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 460
SubjectTerms Air Microbiology
Air Pollution, Indoor
Air Pollution, Indoor - prevention & control
Aspergillosis
Aspergillosis - microbiology
Aspergillosis - prevention & control
Aspergillus
Aspergillus - isolation & purification
Child
Child, Preschool
Colony Count, Microbial
Decontamination
Decontamination - instrumentation
Environment, Controlled
Equipment Design
France
Fungi
Fungi - isolation & purification
Hospitals, Pediatric
Humans
Immunocompromised Host
Infection Control
Infection Control - instrumentation
Infectious Disease
Life Sciences
Microbiology and Parasitology
Mycoses
Mycoses - prevention & control
Title Evaluation of a new mobile system for protecting immune-suppressed patients against airborne contamination
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0196655307004695
https://www.clinicalkey.es/playcontent/1-s2.0-S0196655307004695
https://dx.doi.org/10.1016/j.ajic.2007.02.006
https://www.ncbi.nlm.nih.gov/pubmed/17765558
https://www.proquest.com/docview/68225855
https://hal.science/hal-00690447
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELW67QUJVW35WkqLhbihsEns2MlxVbVaKPQClXqzJo5Ds6LZVbPLkd_OTOxshaBF4mpl8mHPjJ-dN8-MvY1rnUFdycgWWRxJyGOMucxGogAoMfupqh_pzxdqdik_XmVXW-xkqIUhWmXI_T6n99k6tExCb06WTTP5Qsouik690f0iLxuxnVQUCl17Z_rhfHZxp70rlGcyFioig1A742leMG8GJUOS7lT3zU-jayJK3odC-9nobI_tBhjJp_5N99mWaw_YY78Hx31p0RM2P91IefNFzYEjhOY3ixITAfcKzhwhKw9SDTiH8YaqRVzUrZc9P9ZVPOiudhy-QYNQkkNzi27TOk4kdyAiDd3_Kbs8O_16MovC2QqRlYVcRdi9lRC4nlHO2coCYFKkYkoJGOUujcHWeYlQwda6xDWPtjazCAdKWQG4qkzEM7bdLlr3gvE6zS2kZZ0Lp6WUWSFA54Djgq0S8cKYJUOPGhuEx-n8i-9mYJjNDY0CnYipTZyamGzebWyWXnbjwavFMFBmKCjFFGhwVnjQSv_NynUhijuTmA6vNH942phlG8vfnPWfT3yDXrT5IFL2nk0_GWrrFaOl1D-SMXs9OJnBUKf_N9C6xbozCsEcru7w8c-97911jdaKhNte_ueLHbJHfs-auHOv2Pbqdu2OEGytymM2ev8zOQ4h9Qsxiigo
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB615QASqnizfVqIGwqb3Th2cqyqVlvY9kIr9WZNHAeyguyq2eXIb2cmdrZCtEXiannysGfGn5NvPgO8jyudYlXKyOZpHEnMYoq51EZJjlhQ9lNlN9PnF2pyJT9dp9cbcNzXwjCtMuR-n9O7bB1ahmE0h4u6Hn5hZRfFp97obpOXbsIjSeHL0fnx1y3PI0-U5zHmKuLuoXLGk7xwVvc6hizcqe5bnTa_MU3yPgzarUWnz2A7gEhx5J_zOWy45gU89V_ghC8segmzk7WQt5hXAgUBaPFjXlAaEF6_WRBgFUGogVYwUXOtiIva1aJjx7pSBNXVVuBXrAlICqxvyGkaJ5jijkyj4eu_gqvTk8vjSRROVoiszOUyosEtk4R2M8o5W1pESolcSimRYtyNY7RVVhBQsJUuaMejrU0tgYFCloiuLEbJa9hq5o17C6IaZxbHRZUlTksp0zxBnSHNCrVKQgsDGPUjamyQHefTL76bnl82MzwLfB6mNvHYxGzzYW2z8KIbD_ZO-okyfTkpJUBDa8KDVvouK9eGGG7NyLTU0_zlZwNI15Z_uOo_7_iOvGj9QqzrPTmaGm7r9KKl1D9HAzjsncxQoPPfG2zcfNUaRVCO9nZ0-zfe926HRmvFsm07__lgh_B4cnk-NdOzi8-78MR_vWYW3R5sLW9Wbp9g17I46MLqN6CpKOw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+a+new+mobile+system+for+protecting+immune-suppressed+patients+against+airborne+contamination&rft.jtitle=American+journal+of+infection+control&rft.au=Poirot%2C+Jean-Louis%2C+MD&rft.au=Gangneux%2C+Jean-Pierre%2C+MD&rft.au=Fischer%2C+Alain%2C+MD%2C+PhD&rft.au=Malbernard%2C+Mireille%2C+RN&rft.date=2007-09-01&rft.issn=0196-6553&rft.volume=35&rft.issue=7&rft.spage=460&rft.epage=466&rft_id=info:doi/10.1016%2Fj.ajic.2007.02.006&rft.externalDBID=ECK1-s2.0-S0196655307004695&rft.externalDocID=1_s2_0_S0196655307004695
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01966553%2FS0196655307X01482%2Fcov150h.gif